Reata Pharmaceuticals (RETA) Stock Forecast for 2025, 2026, 2027. Sell or Buy Prediction







How Measurement and Mix Modeling Drive Better Business Decisions

May 22, 2025 How Measurement and Mix Modeling Drive Better Business Decisions

In today’s data-driven business landscape, the ability to accurately measure and optimize marketing efforts has become a critical competitive advantage. As marketing evolves,…
Are you making these mistakes when analyzing candlestick patterns?

May 22, 2025 Are you making these mistakes when analyzing candlestick patterns?

Trading is a very popular endeavor these days, and for good reason, as it is widely accessible and allows individuals to generate additional…
Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

What defines a successful crypto expert? The amount of money earned, the number of luxury cars and international real estate? The presence of…
Features of exchanging USDC ERC20 to Bank Transfer

March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer

You can use electronic exchange services if you need to exchange the digital asset USDC ERC20 to Bank Transfer. It is not recommended…
Why Stock Caps Matter When Building a Diversified Portfolio

February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio

Most investors who want to expand their investment options put their money in different asset types and industries across many areas in the…

Reata Pharmaceuticals (RETA) Stock Forecast for 2025, 2026, 2027. Sell or Buy?

Updated: May 24, 2025 (19:21)

Sector: Healthcare

The share price of Reata Pharmaceuticals, Inc. (RETA) now

This company is DELISTED
Latest session on the 26th of September for
Reata Pharmaceuticals, Inc. is negative
Trading Volume: 0
Open: 172.36 /  High: 172.36 /  Low: 172.36
Current value: $172.36

Are you interested in Reata Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Reata Pharmaceuticals stock price in 2025, 2026, 2027. How much will one Reata Pharmaceuticals share be worth in 2025 - 2027?

When should I take profit in Reata Pharmaceuticals stock? When should I record a loss on Reata Pharmaceuticals stock? What are analysts' forecasts for Reata Pharmaceuticals stock? What is the future of Reata Pharmaceuticals stock? We forecast Reata Pharmaceuticals stock performance using neural networks based on historical data on Reata Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Reata Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Reata Pharmaceuticals shares. This happens once a day.


Historical and forecast chart of Reata Pharmaceuticals stock

The chart below shows the historical price of Reata Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Reata Pharmaceuticals stock price can be found in the table below.

No data

Long-term forecasts by years.

Reata Pharmaceuticals, Inc., a clinical biopharmaceutical company, is developing new therapies for patients with serious or life-threatening illnesses by targeting molecular pathways that regulate cellular metabolism and inflammation.

Trending Themes in the Healthcare Sector

Reata Pharmaceuticals daily forecast for a month

Date Target Pes. Opt. Vol., %
May 26 172.36 172.36 172.36 0.00
May 27 172.36 172.36 172.36 0.00
May 28 172.36 172.36 172.36 0.00
May 29 172.36 172.36 172.36 0.00
May 30 172.36 172.36 172.36 0.00
May 31 172.36 172.36 172.36 0.00
Jun 01 172.36 172.36 172.36 0.00
Jun 02 172.36 172.36 172.36 0.00
Jun 03 172.36 172.36 172.36 0.00
Jun 04 172.36 172.36 172.36 0.00
Jun 05 172.36 172.36 172.36 0.00
Jun 06 172.36 172.36 172.36 0.00
Jun 07 172.36 172.36 172.36 0.00
Jun 08 172.36 172.36 172.36 0.00
Jun 09 172.36 172.36 172.36 0.00
Jun 10 172.36 172.36 172.36 0.00
Jun 11 172.36 172.36 172.36 0.00
Jun 12 172.36 172.36 172.36 0.00
Jun 13 172.36 172.36 172.36 0.00
Jun 14 172.36 172.36 172.36 0.00
Jun 15 172.36 172.36 172.36 0.00
Jun 16 172.36 172.36 172.36 0.00
Jun 17 172.36 172.36 172.36 0.00
Jun 18 172.36 172.36 172.36 0.00
Jun 19 172.36 172.36 172.36 0.00
Jun 20 172.36 172.36 172.36 0.00
Jun 21 172.36 172.36 172.36 0.00
Jun 22 172.36 172.36 172.36 0.00
Jun 23 172.36 172.36 172.36 0.00
Jun 24 172.36 172.36 172.36 0.00

Reata Pharmaceuticals Daily Price Targets


Reata Pharmaceuticals Stock Forecast 05-26-2025.

Forecast target price for 05-26-2025: $172.36.
Negative dynamics for Reata Pharmaceuticals shares will prevail with possible volatility of 0.000%.
Pessimistic target level: 172.36
Optimistic target level: 172.36

Reata Pharmaceuticals Stock Forecast 05-27-2025.

Forecast target price for 05-27-2025: $172.36.
Negative dynamics for Reata Pharmaceuticals shares will prevail with possible volatility of 0.000%.
Pessimistic target level: 172.36
Optimistic target level: 172.36

Reata Pharmaceuticals Stock Forecast 05-28-2025.

Forecast target price for 05-28-2025: $172.36.
Negative dynamics for Reata Pharmaceuticals shares will prevail with possible volatility of 0.000%.
Pessimistic target level: 172.36
Optimistic target level: 172.36

Reata Pharmaceuticals Stock Forecast 05-29-2025.

Forecast target price for 05-29-2025: $172.36.
Negative dynamics for Reata Pharmaceuticals shares will prevail with possible volatility of 0.000%.
Pessimistic target level: 172.36
Optimistic target level: 172.36

Reata Pharmaceuticals Stock Forecast 05-30-2025.

Forecast target price for 05-30-2025: $172.36.
Negative dynamics for Reata Pharmaceuticals shares will prevail with possible volatility of 0.000%.
Pessimistic target level: 172.36
Optimistic target level: 172.36

Reata Pharmaceuticals Stock Forecast 05-31-2025.

Forecast target price for 05-31-2025: $172.36.
Negative dynamics for Reata Pharmaceuticals shares will prevail with possible volatility of 0.000%.
Pessimistic target level: 172.36
Optimistic target level: 172.36

RETA (RETA) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jun. 173.46 137.94 205.66 32.93
Jul. 211.76 183.98 265.30 30.65
Aug. 231.42 176.62 252.15 29.96
Sep. 246.97 221.68 296.76 25.30
Oct. 191.65 147.49 235.80 37.45
Nov. 236.42 199.35 281.81 29.26
Dec. 215.23 171.15 263.44 35.03

Reata Pharmaceuticals forecast for this year


Reata Pharmaceuticals Stock Prediction for Jun 2025

An uptrend is forecast for this month with an optimal target price of $173.463. Pessimistic: $137.94. Optimistic: $205.66


Reata Pharmaceuticals Stock Prediction for Jul 2025

An uptrend is forecast for this month with an optimal target price of $211.764. Pessimistic: $183.98. Optimistic: $265.30


Reata Pharmaceuticals Stock Prediction for Aug 2025

An uptrend is forecast for this month with an optimal target price of $231.415. Pessimistic: $176.62. Optimistic: $252.15


Reata Pharmaceuticals Stock Prediction for Sep 2025

An uptrend is forecast for this month with an optimal target price of $246.967. Pessimistic: $221.68. Optimistic: $296.76


Reata Pharmaceuticals Stock Prediction for Oct 2025

An downtrend is forecast for this month with an optimal target price of $191.646. Pessimistic: $147.49. Optimistic: $235.80


Reata Pharmaceuticals Stock Prediction for Nov 2025

An uptrend is forecast for this month with an optimal target price of $236.415. Pessimistic: $199.35. Optimistic: $281.81


Reata Pharmaceuticals Stock Prediction for Dec 2025

An downtrend is forecast for this month with an optimal target price of $215.232. Pessimistic: $171.15. Optimistic: $263.44



Reata Pharmaceuticals (RETA) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 200.77 150.66 252.17 40.25
Feb 201.41 175.63 242.66 27.62
Mar 174.34 159.28 189.40 15.91
Apr 181.04 146.28 221.01 33.81
May 173.51 150.74 189.61 20.50
Jun 164.07 123.12 183.49 32.90
Jul 190.32 161.69 235.38 31.31
Aug 181.79 137.00 195.75 30.02
Sep 208.55 191.87 224.57 14.56
Oct 211.22 174.05 249.07 30.12
Nov 233.52 195.41 256.69 23.87
Dec 224.56 201.56 245.40 17.86

Reata Pharmaceuticals (RETA) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 204.44 164.53 252.85 34.93
Feb 207.71 172.48 258.22 33.20
Mar 187.77 155.92 227.42 31.44
Apr 168.54 156.68 186.34 15.92
May 145.35 124.88 157.91 20.91
Jun 156.51 136.48 181.55 24.83
Jul 136.98 109.80 165.47 33.64
Aug 116.38 91.05 127.18 28.40
Sep 90.31 74.13 102.74 27.85
Oct 90.02 74.75 108.17 30.89
Nov 102.12 85.13 114.54 25.68
Dec 107.02 89.55 125.51 28.65

Reata Pharmaceuticals information and performance

Reata Pharmaceuticals Address

N/A

Market Capitalization: N/A $

Market capitalization of the Reata Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of RETA shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA of Reata Pharmaceuticals is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

FAQ (Frequently Asked Questions about Reata Pharmaceuticals Stock)

Should I Buy Reata Pharmaceuticals Shares in 2025 year?

The maximum forecasted share price for next year is $233.52, which is $61.16 higher than the current stock price. By investing in Reata Pharmaceuticals shares today for a one-year period, you could achieve a profit of 35.49%. With an investment horizon of up to two years, the target share price is $207.71. resulting in a profit of 20.51% ($35.35 per share).

Does Reata Pharmaceuticals pay dividends?

No, it does not

Which economic sector do Reata Pharmaceuticals's shares belong to?

Reata Pharmaceuticals's shares belong to the "Healthcare" sector of economic.

Which other securities belong to the same sector as Reata Pharmaceuticals's shares?

You can view all the stocks that are part of the same sector as Reata Pharmaceuticals's shares in the Healthcare section.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.